Stein Kevin D, Jacobsen Paul B, Blanchard Chris M, Thors Christina
American Cancer Society Behavioral Research Center, Atlanta, Georgia, USA.
J Pain Symptom Manage. 2004 Jan;27(1):14-23. doi: 10.1016/j.jpainsymman.2003.06.003.
A growing body of evidence is documenting the multidimensional nature of cancer-related fatigue. Although several multidimensional measures of fatigue have been developed, further validation of these scales is needed. To this end, the current study sought to evaluate the factorial and construct validity of the 30-item Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF). A heterogeneous sample of 304 cancer patients (mean age 55 years) completed the MFSI-SF, along with several other measures of psychosocial functioning including the MOS-SF-36 and Fatigue Symptom Inventory, following the fourth cycle of chemotherapy treatment. The results of a confirmatory factor analysis indicated the 5-factor model provided a good fit to the data as evidenced by commonly used goodness of fit indices (CFI 0.90 and IFI 0.90). Additional evidence for the validity of the MFSI-SF was provided via correlations with other relevant instruments (range -0.21 to 0.82). In sum, the current study provides support for the MFSI-SF as a valuable tool for the multidimensional assessment of cancer-related fatigue.
越来越多的证据证明了癌症相关疲劳的多维度性质。尽管已经开发了几种疲劳的多维度测量方法，但这些量表仍需要进一步验证。为此，本研究旨在评估30项多维疲劳症状量表简表（MFSI-SF）的因子效度和结构效度。304名癌症患者（平均年龄55岁）的异质性样本在化疗治疗的第四个周期后，完成了MFSI-SF以及其他一些心理社会功能测量，包括MOS-SF-36和疲劳症状量表。验证性因子分析结果表明，常用的拟合优度指标（CFI 0.90和IFI 0.90）证明五因子模型与数据拟合良好。通过与其他相关工具的相关性（范围为-0.21至0.82），为MFSI-SF的效度提供了额外证据。总之，本研究支持将MFSI-SF作为癌症相关疲劳多维度评估的有价值工具。
